Medicaid

Hospital medicaid

First Opinion

An insider’s view of the myths and misconceptions behind 340B ‘reform’

By Bradford R. Lang

Prison

Pharmalot

Can a federal drug discount program unlock savings for state prisons?

By Ed Silverman

advertisement

Seema Verma

Politics

Which drug makers’ medicines are racking up bigger and bigger bills for Medicare and Medicaid?

By Erin Mershon

advertisement

Rep. Peter Welch

Pharmalot

Lawmakers introduce bill to fine drug makers for incorrect Medicaid classifications

By Ed Silverman

Boston Children’s Hospital

First Opinion

Medicaid’s unnecessary barriers delay care for children with complex needs

By Nick Manetto, Joshua Greenberg, and Mathieu Gaulin

Amazon Berkshire JPM Health Care

Business

Bill Gates is glad Amazon is getting into health care — but cautions it’s complicated

By Megan Thielking

Pharmalot

Pharmalittle: Has ‘right to try’ legislation stalled? Probes into copay charities are slowing contributions

By Ed Silverman

advertisement

Vertex Pharmaceuticals Inc. building

Pharmalot

New York panel votes to lower the cost of a pricey Vertex drug for cystic fibrosis

By Ed Silverman

advertisement

Pharmalot

Pharmalot

How a patient advocacy group is used to promote an Insys drug and other fentanyl meds

By Ed Silverman

Vertex

Pharmalot

New York panel to review Vertex pricing in first test of new law

By Ed Silverman

Pill pack

Business

Feds broaden the definition of ‘pharmacy’ in a bid to level playing field for startups

Generics

Pharmalot

To boost generic competition, analysis says, FDA should approve drugs OK’d by foreign regulators

By Ed Silverman

Patient data and tech

Business

The government wants to free your health data. Will that unleash innovation?

Generic medication

Pharmalot

Vermont transparency pricing law may show big price hikes, but disappoints lawmakers

By Ed Silverman

Vertex

Pharmalot

Vertex battles with the U.K. over the price of its cystic fibrosis drug

By Ed Silverman

Gilead Sciences

Pharmalot

HHS is urged to investigate a Gilead hepatitis C patent for failing to disclose federal funding

By Ed Silverman

Medicaid work requirement

First Opinion

Medicaid work requirements are bad for patients and physicians

By Jack Ende

Elijah Cummings 2017

Pharmalot

Lawmakers urge HHS to sidestep patents on hepatitis C drugs

By Ed Silverman

SHAPE SORTER Meds

Pharma

Did the government overpay for hundreds of drugs? It’s complicated

By Ike Swetlitz

Alternative Medicine Symposium

Politics

As the opioid crisis grows, states are opening Medicaid to alternative medicine

Wedowee Hospital - Alabama

Hospitals

In states that didn’t expand Medicaid, hospital closures have spiked

Pharmalot

Pharmalittle: Pharma accounted for a lot of fraud last year; what becomes of Apotex?

By Ed Silverman

Three to Watch - Political Issues for Hospitals

Hospitals

3 political issues for hospitals to watch in 2018

Hospital medicaid

First Opinion

Physicians who refuse to accept Medicaid patients breach their contract with society

By Sumit Agarwal

Rising drug cost

Pharmalot

Arizona becomes the latest state to seek to limit Medicaid drug coverage

By Ed Silverman

Hep C San Fran

Pharmalot

Colorado lifts Medicaid restrictions for treating hepatitis C

By Ed Silverman

Hep C

Health

With cures in hand, a major city tries to eliminate hepatitis C — and build a model for others

By Andrew Joseph

Medication

First Opinion

Medicaid ‘best price’ approach to drug costs needs an upgrade

By Joel White

Remote Area Medical Treats Patients In Underserved Communities In Florida

First Opinion

The problem with American health care is the care

By Shreya Kangovi